Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2005

Study Completion Date

May 31, 2007

Conditions
Low Back PainMigraineDiabetic NeuropathiesOsteoarthritis
Interventions
DRUG

OraVescent Fentanyl

Trial Locations (38)

10016

NYU Pain Management Center, New York

10022

Research Across America, New York

11714

Northshore University Hospital, Bethpage

19611

Clinical Research Center of Reading, LLP, West Reading

20852

Capital Clinical Research Associates, LLC, Rockville

30060

Center for Prospective Outcome Studies, Inc., Marietta

30076

North Fulton Regional Hospital Pain Center, Roswell

30080

Carmen Research, Smyrna

30327

Center for Prospective Outcome Studies, Inc., Atlanta

30342

Advent Clinical Research Centers, Inc., Atlanta

32114

Radiant Research-Daytona Beach, Daytona Beach

33331

Gold Coast Research, Weston

33703

Advent Clinical Research Centers, Inc., St. Petersburg

35040

MedSearch, Calera

35216

Clinical Research Consultants, Inc., Hoover

37813

Healthstar Physicians, Morristown

47714

Medisphere Medical Research Center, LLC, Evansville

Tri-State Arthritis & Rheumatology Center, LLC, Evansville

50265

Iowa Pain Management Clinic, PC, Des Moines

63108

Medex Healthcare Research Center, St Louis

63141

Radiant Research - St. Louis, St Louis

66211

Mid-America Physiatrists, PA, Overland Park

72404

NEA Clinic, Jonesboro

73112

The Lynn Health Science Institute, Oklahoma City

77479

Biopharma Research Associates, Sugar Land

80909

Lynn Institute of the Rockies, Colorado Springs

83702

Orthopedic Health Care, Boise

84106

Lifetree Clinical Research, Salt Lake City

84107

Radiant Research, Salt Lake City

84112

Huntsman Cancer Institute, Salt Lake City

85023

Arizona Research Center, Phoenix

89104

Clinical Research Center of Nevada, Las Vegas

97504

Southern Oregon Health & Wellness, Medford

98004

Northwest Clinical Research Center, Bellevue

99207

Rowan Research, Spokane

02115

Brigham Women's Hospital, Attn: Pain Trials Center, Boston

02481-2106

MedVadis Research, Wellesley Hills

05403

Pain Management Center, South Burlington

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cephalon

INDUSTRY

NCT00228605 - Evaluating the Safety and Tolerability of OraVescent Fentanyl for Opioid Tolerant Patients With Noncancer Related Breakthrough Pain | Biotech Hunter | Biotech Hunter